搜尋結果
2022
Hsu, F. C. ,
Lee, H. L. ,
Chen, Y. J. ,
Shen, Y. A. ,
Tsai, Y. C. ,
Wu, M. H. ,
Kuo, C. C. ,
Lu, L. S. ,
Yeh, S. D. ,
Huang, W. S. ,
Shen, C. N. &
Chiou, J. F. ,
1月 1 2022 ,
於: Cancers. 14 ,
2 , 445.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Magnetic Resonance Spectroscopy
100%
Learning
87%
Cytokines
73%
Bone and Bones
70%
Interleukin-6
34%
Chien, S. C. ,
Chen, Y. L. ,
Chien, C. H. ,
Chin, Y. P. ,
Yoon, C. H. ,
Chen, C. Y. ,
Yang, H. C. &
Li, Y. C. ,
4月 2022 ,
於: Healthcare (Switzerland). 10 ,
4 , 601.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Bibliometrics
100%
Clinical Decision Support Systems
93%
clinical decisions
90%
content analysis
53%
Direction compound
39%
Zheng, C. M. ,
Chiu, I. J. ,
Chen, Y. W. ,
Hsu, Y. H. ,
Hung, L. Y. ,
Wu, M. Y. ,
Lin, Y. F. ,
Liao, C. T. ,
Hung, Y. P. ,
Tsai, C. C. ,
Cherng, Y. G. &
Wu, M. S. ,
2022 , (接受/付印)
於: Journal of Cellular and Molecular Medicine. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Glomerular Filtration Rate
100%
Chronic Renal Insufficiency
96%
Adipose Tissue
87%
Stem Cells
77%
Safety
61%
Mokgautsi, N. ,
Kuo, Y. C. ,
Tang, S. L. ,
Liu, F. C. ,
Chen, S. J. ,
Wu, A. T. H. &
Huang, H. S. ,
1月 1 2022 ,
於: Cancers. 14 ,
1 , 262.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Mitogen-Activated Protein Kinase 7
100%
Glioblastoma
87%
Cell Cycle
70%
Cyclin B1
65%
Temozolomide
24%
Lee, Y. H. ,
Tsai, Y. S. ,
Chang, C. C. ,
Ho, C. C. ,
Shih, H. M. ,
Chen, H. M. ,
Lai, H. L. ,
Lee, C. W. ,
Lee, Y. C. ,
Liao, Y. C. ,
Yang, U. C. ,
Cheng, T. H. ,
Chern, Y. &
Soong, B. W. ,
4月 2022 ,
於: Movement Disorders. 37 ,
4 ,
p. 767-777 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
polyglutamine
100%
Proteostasis
99%
Huntington Disease
65%
Machado-Joseph Disease
25%
Huntingtin Protein
12%
Yeh, L-Y. ,
Fang, Y-T. ,
Lee, H-S. ,
Liu, C-H. ,
Chen, Y-Y. ,
Lo, Y-C. ,
Laiman, V. ,
Liou, J-P. ,
Chung, K. F. ,
Chuang, H-C. &
Lin, C-H. ,
5月 2022 ,
於: Frontiers in Medicine. 9 研究成果: 雜誌貢獻 › 文章 › 同行評審
3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide
100%
Histone Deacetylase Inhibitors
49%
Emphysema
47%
Body Weight
22%
Pancreatic Elastase
9%
Liu, Y. L. ,
Tsai, M. L. ,
Chen, C. I. ,
Yar, N. ,
Tsai, C. W. ,
Lee, H. L. ,
Kuo, C. C. ,
Ho, W. L. ,
Hsieh, K. L. C. ,
Tseng, S. H. ,
Miser, J. S. ,
Chang, C. Y. ,
Chang, H. ,
Huang, W. C. ,
Wong, T. T. ,
Wu, A. T. H. &
Yen, Y. C. ,
2月 1 2022 ,
於: Cancers. 14 ,
3 , 668.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Atypical Teratoid Tumor
99%
Taiwan
62%
Radiotherapy
34%
Population
24%
Drug Therapy
22%
Cheng, W. J. ,
Chuang, K. H. ,
Lo, Y. J. ,
Chen, M. ,
Chen, Y. J. ,
Roffler, S. R. ,
Ho, H. O. ,
Lin, S. Y. &
Sheu, M. T. ,
4月 2022 ,
於: Journal of Controlled Release. 344 ,
p. 235-248 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
STA 9090
100%
Nanocarrier
57%
Glycol
49%
T-Lymphocytes
33%
Decoration
29%
Lin, Y. C. ,
Liao, C. T. ,
Zheng, C. M. ,
Lin, M. H. ,
Hsu, C. C. ,
Hsu, Y. H. &
Wu, M. S. ,
2022 , (接受/付印)
於: Journal of the Formosan Medical Association. 121 ,
p. S56-S63 研究成果: 雜誌貢獻 › 文章 › 同行評審
Taiwan
100%
Dialysis
86%
Contrast Media
38%
General Anesthesia
38%
Chronic Renal Insufficiency
30%
Huang, W. C. ,
Hou, S. M. ,
Wu, M. P. ,
Hsia, C. H. ,
Jayakumar, T. ,
Hsia, C. H. ,
Bhavan, P. S. ,
Chung, C. L. &
Sheu, J. R. ,
1月 1 2022 ,
於: Molecules. 27 ,
2 , 476.
研究成果: 雜誌貢獻 › 文章 › 同行評審
3-(4-methylphenylsulfonyl)-2-propenenitrile
89%
thrombosis
85%
inhibitors
64%
Platelet Activation
61%
platelets
60%
Hsiu, H. ,
Liu, J. C. ,
Yang, C. J. ,
Chen, H. S. ,
Wu, M. S. ,
Hao, W. R. ,
Lee, K. Y. ,
Hu, C. J. ,
Wang, Y. H. &
Fang, Y. A. ,
1月 2022 ,
於: Microvascular Research. 139 , 104240.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Pulse
100%
Machine Learning
99%
Multilayer
77%
Cardio Ankle Vascular Index
57%
Blood Vessels
51%
Chung, W. C. ,
Kao, C. C. ,
Huang, C. F. ,
Lee, C. Y. ,
Lu, H. K. &
Wu, M. S. ,
2月 1 2022 ,
於: International journal of environmental research and public health. 19 ,
3 , 1533.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Periodontitis
100%
Biological Marker
82%
Renal Insufficiency
80%
therapy
65%
Pathogens
61%
Wu, K. S. ,
Jian, T. Y. ,
Sung, S. Y. ,
Hsieh, C. L. ,
Huang, M. H. ,
Fang, C. L. ,
Wong, T. T. &
Lin, Y. L. ,
5月 1 2022 ,
於: International journal of molecular sciences. 23 ,
9 , 5287.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Medulloblastoma
100%
Tumors
83%
Cells
79%
tumors
78%
B-Lymphocytes
63%
Chiang, M. D. ,
Chang, C. Y. ,
Shih, H. J. ,
Le, V. L. ,
Huang, Y. H. &
Huang, C. J. ,
4月 2022 ,
於: Antioxidants. 11 ,
4 , 615.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Obese Mice
100%
Exosomes
96%
Endoplasmic Reticulum Stress
91%
Lipopolysaccharide
89%
Lung Injury
86%
Lin, S. J. ,
Huang, J. Y. ,
Le, P. T. ,
Lee, C. T. ,
Chang, C. C. ,
Yang, Y. Y. ,
Su, E. C. Y. ,
Lo, C. F. &
Wang, H. C. ,
3月 1 2022 ,
於: International journal of molecular sciences. 23 ,
5 , 2889.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Vibrio parahaemolyticus
100%
necrosis
96%
Quorum Sensing
89%
Toxin
67%
Genes
67%
Tsai, Y-T. ,
Li, C-Y. ,
Huang, Y-H. ,
Chang, T-S. ,
Lin, C-Y. ,
Chuang, C-H. ,
Wang, C-Y. ,
Anuraga, G. ,
Chang, T-H. ,
Shih, T-C. ,
Lin, Z-Y. ,
Chen, Y-L. ,
Chung, I. ,
Lee, K-H. ,
Chang, C-C. ,
Sung, S-Y. ,
Yang, K-H. ,
Tsui, W-L. ,
Yap, C-V. &
Wu, M-H. ,
4月 22 2022 , (打印前電子出版)
於: Oncogene. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Galectin 1
100%
Protein Stability
80%
Tumor Necrosis Factor Receptors
78%
Hepatocellular Carcinoma
54%
Fibroblasts
50%
Wu, A. TH. ,
Yeh, Y. C. ,
Huang, Y. J. ,
Mokgautsi, N. ,
Lawal, B. &
Huang, T. H. ,
1月 2022 ,
於: Phytomedicine. 95 , 153797.
研究成果: 雜誌貢獻 › 文章 › 同行評審
gamma-mangostin
100%
Gamma-Mangostin
97%
Garcinia mangostana
84%
Catenins
63%
Cancer-Associated Fibroblasts
58%
Yang, H. C. ,
Rahmanti, A. R. ,
Huang, C. W. &
Jack Li, Y. C. ,
3月 2022 ,
於: Journal of Medical Internet Research. 24 ,
3 , e29506.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Emotions
100%
Psychology Recognition
83%
Facial Recognition
82%
Datasets
75%
Technology
62%
Lin, T. E. ,
Chao, M. W. ,
HuangFu, W. C. ,
Tu, H. J. ,
Peng, Z. X. ,
Su, C. J. ,
Sung, T. Y. ,
Hsieh, J. H. ,
Lee, C. C. ,
Yang, C. R. ,
Pan, S. L. &
Hsu, K. C. ,
2月 2022 ,
於: Biomedicine and Pharmacotherapy. 146 , 112580.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Neurodegenerative Diseases
100%
Structure-Activity Relationship
44%
Enzyme Assays
43%
Computer Simulation
36%
Catalytic Domain
34%
Wu, A. T. H. ,
Lawal, B. ,
Tzeng, Y. M. ,
Shih, C. C. &
Shih, C. M. ,
2月 1 2022 ,
於: International journal of molecular sciences. 23 ,
3 , 1281.
研究成果: 雜誌貢獻 › 文章 › 同行評審
ovatodiolide
100%
Theranostics
91%
myocardial infarction
75%
Diterpenes
63%
Theranostic Nanomedicine
62%
Cheng, S. Y. ,
Wu, A. T. H. ,
Batiha, G. E. S. ,
Ho, C. L. ,
Lee, J. C. ,
Lukman, H. Y. ,
Alorabi, M. ,
Alrasheedi, A. N. &
Chen, J. H. ,
2月 2022 ,
於: Biology. 11 ,
2 , 324.
研究成果: 雜誌貢獻 › 文章 › 同行評審
thyroid neoplasms
100%
precision medicine
99%
Sitagliptin
99%
Sitagliptin Phosphate
86%
Theranostic Nanomedicine
80%
Chang, C. Y. ,
Chen, K. Y. ,
Shih, H. J. ,
Chiang, M. ,
Huang, I. T. ,
Huang, Y. H. &
Huang, C. J. ,
1月 2022 ,
於: Pharmaceuticals. 15 ,
1 , 36.
研究成果: 雜誌貢獻 › 文章 › 同行評審
MicroRNA
100%
Obese Mice
99%
Exosomes
96%
High Fat Diet
81%
Endotoxins
81%
Lee, C. T. ,
Lee, C. C. ,
Wu, M. J. ,
Chiu, Y. W. ,
Leu, J. G. ,
Wu, M. S. ,
Peng, Y. S. ,
Wu, M. S. &
Tarng, D. C. ,
3月 2022 ,
於: PLoS ONE. 17 ,
3 March , e0264727.
研究成果: 雜誌貢獻 › 文章 › 同行評審
ferric citrate
100%
Renal Dialysis
51%
Phosphates
51%
Iron
49%
Safety
34%
Leung, W. H. ,
Shih, J. W. ,
Chen, J. S. ,
Mokgautsi, N. ,
Wei, P. L. &
Huang, Y. J. ,
2月 2022 ,
於: Biomedicines. 10 ,
2 , 377.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Sulfasalazine
100%
Colorectal Neoplasms
48%
Molecular Cluster
39%
Neoplasm Metastasis
37%
Resistance
25%
Wu, M. Y. ,
Hu, P. J. ,
Chen, Y. W. ,
Sung, L. C. ,
Chen, T. T. ,
Wu, M. S. &
Cherng, Y. G. ,
2022 , (接受/付印)
於: Journal of Nephrology. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Dialysis
100%
Cohort Studies
79%
Mortality
59%
Population
45%
Taiwan
33%
Chen, Y. W. ,
Wu, M. Y. ,
Mao, C. H. ,
Yeh, Y. T. ,
Chen, T. T. ,
Liao, C. T. ,
Zheng, C. M. ,
Hsu, Y. H. ,
Cherng, Y. G. &
Wu, M. S. ,
12月 2022 ,
於: Scientific Reports. 12 ,
1 , 6492.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Acute Disease
100%
Kidney Diseases
97%
Acute Kidney Injury
88%
Kidney
50%
Logistic Models
14%
Jayakumar, T. ,
Lin, K. C. ,
Chang, C. C. ,
Hsia, C. H. ,
Manubolu, M. ,
Huang, W. C. ,
Sheu, J. R. &
Hsia, C. H. ,
1月 1 2022 ,
於: International journal of molecular sciences. 23 ,
1 , 92.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Macrophages
93%
macrophages
80%
Transcription factors
79%
Lipopolysaccharide
61%
NF-kappa B
59%
Le, T. T-H. ,
Hsieh, C-L. ,
Lin, I-H. ,
Chu, C-Y. ,
Do, A. D. ,
Chen, S-H. ,
Shigemura, K. ,
Kitagawa, K. ,
Fujisawa, M. ,
Liu, M-C. ,
Chen, K-C. &
Sung, S-Y. ,
2022 ,
於: American Journal of Cancer Research. 12 ,
1 ,
p. 176-197 22 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Aldo-Keto Reductase Family 1 Member C3
100%
Androgens
46%
Prostatic Neoplasms
40%
Cancer-Associated Fibroblasts
20%
Protein Isoforms
11%
Wu, M-Y. ,
Lo, W-C. ,
Wu, Y. C. ,
Lin, T. C. ,
Lin, C. H. ,
Wu, M-S. &
Tu, Y. K. ,
4月 2022 , (接受/付印)
於: Frontiers in Medicine. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Lee, C. Y. ,
Wu, M. Y. ,
Chan, H. C. ,
Chen, T. T. ,
Hsu, L. Y. ,
Wu, M. S. &
Cherng, Y. G. ,
2月 7 2022 ,
於: Transplant International. 36 , 10023.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Liver Transplantation
100%
Chronic Kidney Failure
96%
Diabetes Mellitus
87%
Mortality
55%
Confidence Intervals
23%
Pentylenetetrazole
100%
Valproic Acid
86%
Seizures
61%
Status Epilepticus
32%
Therapeutics
12%
Syed-Abdul, S. ,
Babu, A. S. ,
Bellamkonda, R. S. ,
Itumalla, R. ,
Acharyulu, G. V. R. K. ,
Krishnamurthy, S. ,
Ramana, Y. V. S. ,
Mogilicharla, N. ,
Malwade, S. &
Li, Y. C. ,
2022 , (接受/付印)
於: Journal of Infection. 84 ,
3 ,
p. 351-354 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Mucormycosis
100%
Artificial Intelligence
96%
Public Hospitals
79%
India
63%
Survivors
63%
2021
Liao, C. T. ,
Zheng, C. M. ,
Lin, Y. C. ,
Wu, M. Y. ,
Lin, Y. F. ,
Hsu, Y. H. ,
Hsu, C. C. &
Wu, M. S. ,
1月 13 2021 ,
於: Scientific Reports. 11 ,
1 , 1171.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Peritoneal Dialysis
100%
Phosphorus
97%
Peritonitis
94%
Parathyroid Hormone
92%
Calcium
63%
Chen, J. Y. ,
Cheng, W. H. ,
Lee, K. Y. ,
Kuo, H. P. ,
Chung, K. F. ,
Chen, C. L. ,
Chen, B. C. &
Lin, C. H. ,
8月 2021 ,
於: Biomedicine and Pharmacotherapy. 140 , 111701.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Disintegrins
100%
Metalloproteases
81%
Asthma
59%
Fibrosis
56%
Fibroblasts
18%
Coronavirus
100%
Information Dissemination
93%
Disease Outbreaks
70%
Artificial Intelligence
35%
Pandemics
28%
Ningrum, D. N. A. ,
Kung, W. M. ,
Tzeng, I. S. ,
Yuan, S. P. ,
Wu, C. C. ,
Huang, C. Y. ,
Muhtar, M. S. ,
Nguyen, P. A. ,
Li, Y-C. &
Wang, Y. C. ,
2021 ,
於: Journal of Multidisciplinary Healthcare. 14 ,
p. 2477-2485 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Deep Learning
100%
Knee Osteoarthritis
79%
Medical Records
60%
ROC Curve
16%
Sensitivity and Specificity
9%
Chen, W. J. ,
Lin, I. H. ,
Lee, C. W. &
Chen, Y. F. ,
2月 2 2021 ,
於: International journal of molecular sciences. 22 ,
4 ,
p. 1-14 14 p. , 2123.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Collagen
100%
skeletal muscle
97%
collagens
85%
muscles
79%
Muscle
70%
Huang, S. S. ,
Liao, W. Y. ,
Hsu, C. C. ,
Chan, T. S. ,
Liao, T. Y. ,
Yang, P. M. ,
Chen, L. T. ,
Sung, S. Y. &
Tsai, K. K. ,
5月 31 2021 ,
於: Frontiers in Oncology. 11 ,
p. 638311 638311.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Podosomes
100%
Neoplastic Stem Cells
71%
Caveolin 1
9%
Neoplasms
9%
Surface Properties
9%
Chien, S. C. ,
Chin, Y. P. H. ,
Yoon, C. H. ,
Islam, M. M. ,
Jian, W. S. ,
Hsu, C. K. ,
Chen, C. Y. ,
Chien, P. H. &
Li, Y. C. J. ,
2月 2021 ,
於: PLoS ONE. 16 ,
2 February , e0246597.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Medical Order Entry Systems
100%
physicians
73%
Hospital Administrators
38%
collectors
37%
Programming Languages
19%
Chang, S. C. ,
Hung, C. S. ,
Zhang, B. X. ,
Hsieh, T. H. ,
Hsu, W. &
Ding, J. L. ,
6月 2 2021 ,
於: Cancers. 13 ,
12 , 2873.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Ubiquitin-Protein Ligases
100%
Breast Neoplasms
55%
SKP Cullin F-Box Protein Ligases
48%
Neoplasms
23%
F-Box Proteins
21%
Changou, C. A. ,
Shiah, H. S. ,
Chen, L. T. ,
Liu, S. ,
Luh, F. ,
Liu, S. H. ,
Cheng, Y. C. &
Yen, Y. ,
3月 2021 ,
於: Oncologist. 26 ,
3 ,
p. e367-e373 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
PHY 906
100%
Capecitabine
59%
Hepatocellular Carcinoma
37%
Progression-Free Survival
14%
Safety
13%
Chang, T. K. ,
Yin, T. C. ,
Su, W. C. ,
Tsai, H. L. ,
Huang, C. W. ,
Chen, Y. C. ,
Li, C. C. ,
Chen, P. J. ,
Ma, C. J. ,
Chuang, K. H. ,
Cheng, T. L. &
Wang, J. Y. ,
9月 2021 ,
於: Oncology Research. 28 ,
7 ,
p. 801-809 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Silymarin
100%
Irinotecan
85%
Bevacizumab
81%
Colorectal Neoplasms
57%
Diarrhea
40%
Poly, T. N. ,
Islam, M. M. ,
Jack Li, Y. C. ,
Alsinglawi, B. ,
Hsu, M. H. ,
Jian, W. S. &
Yang, H. C. ,
4月 2021 ,
於: JMIR Medical Informatics. 9 ,
4 , e21394.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Deep Learning
100%
Artificial Intelligence
96%
Meta-Analysis
54%
Radiologists
25%
Pneumonia
22%
Wu, A. T. H. ,
Huang, H. S. ,
Wen, Y. T. ,
Lawal, B. ,
Mokgautsi, N. ,
Huynh, T. T. ,
Hsiao, M. &
Wei, L. ,
9月 11 2021 ,
於: Cells. 10 ,
9 , 2391.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Glioblastoma
100%
TOR Serine-Threonine Kinases
33%
Exosomes
23%
Oncogenes
19%
palbociclib
16%
Islam, M. M. ,
Poly, T. N. ,
Walther, B. A. ,
Lin, M. C. &
Li, Y. C. ,
11月 2021 ,
於: Cancers. 13 ,
21 , 5253.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Artificial Intelligence
100%
Stomach Neoplasms
65%
ROC Curve
27%
Sensitivity and Specificity
16%
Workload
10%
Chin, Y. P. H. ,
Song, W. ,
Lien, C. E. ,
Yoon, C. H. ,
Wang, W. C. ,
Liu, J. ,
Nguyen, P. A. ,
Feng, Y. T. ,
Zhou, L. ,
Li, Y. C. J. &
Bates, D. W. ,
1月 2021 ,
於: JMIR Medical Informatics. 9 ,
1 , e23454.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Medication Errors
100%
Machine Learning
88%
Validation Studies
87%
Internal Medicine
81%
Prescriptions
66%
Wang, W. C. ,
Lin, Y. S. ,
Chang, Y. F. ,
Yeh, C. C. ,
Su, C. T. ,
Wu, J. S. &
Su, F. H. ,
8月 18 2021 ,
於: Frontiers in Immunology. 12 , 710414.
研究成果: 雜誌貢獻 › 文章 › 同行評審
HLA Antigens
100%
Hepatitis B virus
94%
Young Adult
78%
Vaccination
77%
Newborn Infant
74%
Senghore, T. ,
Wang, W. C. ,
Chien, H. T. ,
Chen, Y. X. ,
Young, C. K. ,
Huang, S. F. &
Yeh, C. C. ,
2月 2021 ,
於: Gene. 768 ,
p. 145283 145283.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chemoradiotherapy
100%
Squamous Cell Carcinoma
78%
Survival
51%
Double-Stranded DNA Breaks
35%
Genotype
22%
Chien, S. C. ,
Chin, Y. P. ,
Yoon, C. H. ,
Chen, C. Y. ,
Hsu, C. K. ,
Chien, C. H. &
Li, Y. C. ,
12月 2021 ,
於: Applied Sciences (Switzerland). 11 ,
24 , 12004.
研究成果: 雜誌貢獻 › 文章 › 同行評審
physicians
100%
dwell
89%
entry
78%
Computer programming languages
33%
Detectors
28%
Chi, L-H. ,
Wu, A. T. H. ,
Hsiao, M. &
Li, Y-C. ,
8月 11 2021 ,
於: Journal of Personalized Medicine. 11 ,
8 ,
p. 782 研究成果: 雜誌貢獻 › 文章 › 同行評審
Squamous Cell Carcinoma of Head and Neck
100%
Biomarkers
58%
Datasets
56%
Survival Analysis
52%
Atlases
38%